483 Eli Lilly & Company Jun 2006

483 Eli Lilly & Company Jun 2006

Ernest Bizjak FDA$595.00 - Available Now

FDA investigators audited the Eli Lilly & Company - Indianapolis, IN, United States facility and issued inspectional observations (via FDA 483) on 20 Jun 2006.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Jun 2006
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart